Navigation Links
TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
Date:8/19/2007

mportant milestone for us," said Neil Kurtz, M.D., President and Chief Executive Officer of TorreyPines. "We believe tezampanel has the potential to offer migraine patients an important new treatment option with a novel mechanism of action and we remain on track to announce top line results from the study during the fourth quarter of this year."

In previous clinical trials, tezampanel has been administered to more than 200 healthy adult volunteers or patients. In five Phase IIa, placebo-controlled trials using intravenous administration, tezampanel demonstrated proof of concept in multiple pain models. In one placebo and active-controlled clinical trial in patients with acute migraine, the compound achieved statistical significance in all primary and secondary endpoints traditionally required for regulatory approval. These endpoints included pain relief at two hours, pain-free at two hours and relief of nausea, photophobia and phonophobia.

About AK Receptor Antagonists

AMPA/kainate (AK) receptors are part of the glutamate biological pathway that transmits pain signals to the brain. In addition, these receptors play a critical role in the development of central sensitization phenomena -- a key component of many pain syndromes, including migraine and persistent pain states such as chronic neuropathic pain. AK receptor antagonists selectively bind to certain AK receptors to block transmission of pain signals mediated through the activation of a subtype of glutamate receptors. Because they do not bind to opioid receptors, directly bind to serotonin receptors or constrict blood vessels, the safety profile of AK antagonists may offer important advantages over existing drugs to treat migraine and other chronic pain conditions.

About Migraine

Migraine is a painful neurological condition characterized by an intense and disabling episodic headache. According to the National Headache Foundation, an estimated 30 million people in the U.S. suffer fr
'/>"/>

SOURCE TorreyPines Therapeutics, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
5. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
6. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
7. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
8. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
9. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
10. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
11. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Germany , Aug. 21, 2014  IBM (NYSE: ... Elektronen-Synchrotron ( DESY ), a leading national research center ... management and storage of massive volumes of x-ray data. ... based on IBM software defined technology can handle more ... performance and help scientists worldwide gain faster insights into ...
(Date:8/21/2014)... 2014  Seventy-one percent of Americans believe the abuse of ... public health and safety issue in the United ... today by Repass & Partners, a Cincinnati ... the severity of the prescription medication abuse problem and the ... serious health situation facing our country," Rex Repass , ...
(Date:8/21/2014)... 2014 BreedIT Corp., (OTCQB: ... exclusive worldwide license holder and distributor of highly ... researchers, today is pleased to announce the formation ... Ltd, a leading Israeli medical Cannabis breeder. ... new breeds of medical Cannabis to meet the ...
Breaking Medicine Technology:DESY and IBM Develop Big Data Architecture for Science 2DESY and IBM Develop Big Data Architecture for Science 3Consumers Desperate For Measures To Curb Prescription Drug Abuse 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 4
... BUDAPEST, Hungary , January ... Globally Licenses ChemAxon,s Platform For Markush Structure,Searching And Enumeration , ... cheminformatics software for the life,sciences industry has entered into agreement ... for global,development and deployment within Pfizer,s global R&D facilities. , ...
... ... to Improve Walking for People With All Types of Multiple Sclerosis ... The U.S. Food and Drug Administration has approved the marketing of ... its ability to improve walking speed in people with any type ...
Cached Medicine Technology:Ampyra is First Symptom Management Drug Developed Specifically to Treat MS, the First Oral MS Therapy Approved for MS, and the First New FDA Approved Therapy to Come Through the MS Pipeline Since 2004 2Ampyra is First Symptom Management Drug Developed Specifically to Treat MS, the First Oral MS Therapy Approved for MS, and the First New FDA Approved Therapy to Come Through the MS Pipeline Since 2004 3Ampyra is First Symptom Management Drug Developed Specifically to Treat MS, the First Oral MS Therapy Approved for MS, and the First New FDA Approved Therapy to Come Through the MS Pipeline Since 2004 4Ampyra is First Symptom Management Drug Developed Specifically to Treat MS, the First Oral MS Therapy Approved for MS, and the First New FDA Approved Therapy to Come Through the MS Pipeline Since 2004 5Ampyra is First Symptom Management Drug Developed Specifically to Treat MS, the First Oral MS Therapy Approved for MS, and the First New FDA Approved Therapy to Come Through the MS Pipeline Since 2004 6
(Date:8/22/2014)... The world’s largest, most active billionaire/ millionaire ... millionth member, and it has since greatly exceeded the ... dating website for the rich looking for attractive and ... caters like-minded people who are admirers, millionaires and billionaires. ... , this is the place where rich people can ...
(Date:8/22/2014)... 2014 First Choice Emergency Room ... facility is located at 8927 Highway 6, Missouri City, Texas ... is pleased to be a part of the Missouri City ... medical care to our neighbors here,” said Dr. Kenneth Jones, ... , At yesterday’s ribbon cutting with the Fort ...
(Date:8/22/2014)... Toledo, OH (PRWEB) August 22, 2014 Teen ... people in Toledo, OH. The rising numbers of young adults ... have been staggering. To help make a difference in the ... provide a valuable resource for teens seeking to overcome their ... their teens find the best youth rehab center to focus ...
(Date:8/22/2014)... CA (PRWEB) August 22, 2014 Dr Murray ... for this snoring cure. , In the October 2014 issue ... of Dr Grossan about his method of treating snoring, and ... quotes Dr Grossan: "Nearly half of all adults snore occasionally, ... This is because air passages in the back of ...
(Date:8/21/2014)... Os-Monitor.com, an outstanding online supplier of ... monitoring software collection ( http://www.os-monitor.com ). In addition ... all these high end items are offered with ... of improving productivity, the employers pay more attention ... employee and network monitoring software products are becoming ...
Breaking Medicine News(10 mins):Health News:Rich Men & Women Dating Site Billionairefish.com Exceeds Two Million Members 2Health News:Rich Men & Women Dating Site Billionairefish.com Exceeds Two Million Members 3Health News:First Choice Emergency Room Opens New Facility in Missouri City, Texas 2Health News:New Helpline Provides Hope for Troubled Teens in Toledo 2Health News:Dr Murray Grossan Explains how and why Singing Exercises Stop Snoring 2Health News:Dr Murray Grossan Explains how and why Singing Exercises Stop Snoring 3Health News:New Employee Monitoring Software Collection Unveiled By Os-Monitor.com 2
... , , WASHINGTON, Dec. 21 ... the manager,s amendment which includes abortion language that would force ... that will cover any or all abortions while doing nothing ... the legislation has a myriad of other problems including increasing ...
... More than 40 groups have joined together to oppose ... Vigil" starting at 9 pm tonight and wrapping after the ... millions on the left, right, seniors, tea parties, doctors, libertarians, ... for laying a $200 billion windfall in mandatory premiums at ...
... ... named two QHR management clients to its “Top 100 Hospitals: Best ... a QHR management client since 1982, and Monroe County Hospital (Monroeville, ... company, which specializes in providing hospitals and other healthcare-related businesses with ...
... Political ... for biggest lies also include claims by President Barack Obama and Vice President Joe ... Washington ... of the St. Petersburg Times, has named Sarah Palin,s claim about "death panels" the ...
... , WASHINGTON, Dec. 20 Following is the ... http://www.newscom.com/cgi-bin/prnh/20090226/CENSUSLOGO ) , SUNDAY, DECEMBER 20: FIRST ORGAN ... The first successful organ transplant in the U.S. was performed this ... He transplanted a kidney from one identical twin to another, who ...
... care focuses on costs, a new study from North Carolina ... think of health care spending as an investment that can ... of health care costs and financing may be unduly pessimistic. ... in future capital, contributing to a productive workforce, rather than ...
Cached Medicine News:Health News:FRC Asks - 'Is There No Democratic Senator Who Cares About Life?' 2Health News:Left/Right Healthcare 'Virtual Vigil' Tonight at 9 PM Until Senate Votes; Broad Coalition Says Punishes Some States, Windfall for Insurance Companies 2Health News:QHR Hospital Clients Fort Madison Community Hospital, Monroe County Hospital Named to “Best in Value” Top 100 List 2Health News:PolitiFact Names 'Death Panels' Claim the Lie of the Year 2Health News:U.S. Census Bureau Daily Feature for Dec. 20 2Health News:Study shows health care spending spurs economic growth 2
... Slab Gel Dryer accommodates large sequencing gels or multiple ... coated platen for long lasting durability and corrosion resistance., ... , Quick Drying Rate - large sequence ... , Digital display of temperature and time ...
... The Slimline SGD5040 Slab Gel Dryer incorporates sturdy metal ... saving design. The large surface area makes it perfect ... ones., Slim Profile 40cm x 50cm (W ... Heat Ramping Rates allows you to optimize ...
... midi gel dryer can dry 6 pieces of 10 ... area is 21 x 31 cm for laboratories to ... of silicon rubber with mask. Microprocessor controller controls temperature ... and the vacuum removes the moisture from below to ...
... dry gels rapidly, evenly and safely, the Hoefer ... and vacuum are applied beneath the gel through ... and agarose gels up to 33 x 44 ... heavy aluminum platen provides even heat distribution and ...
Medicine Products: